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Abstract. Visualizing and interpreting convolutional neural networks
(CNNs) is an important task to increase trust in automatic medical
decision making systems. In this study, we train a 3D CNN to detect
Alzheimer’s disease based on structural MRI scans of the brain. Then,
we apply four different gradient-based and occlusion-based visualization
methods that explain the network’s classification decisions by highlight-
ing relevant areas in the input image. We compare the methods qualita-
tively and quantitatively. We find that all four methods focus on brain
regions known to be involved in Alzheimer’s disease, such as inferior and
middle temporal gyrus. While the occlusion-based methods focus more
on specific regions, the gradient-based methods pick up distributed rel-
evance patterns. Additionally, we find that the distribution of relevance
varies across patients, with some having a stronger focus on the temporal
lobe, whereas for others more cortical areas are relevant. In summary,
we show that applying different visualization methods is important to
understand the decisions of a CNN, a step that is crucial to increase
clinical impact and trust in computer-based decision support systems.
Keywords: Alzheimer · Visualization · MRI · Deep Learning · CNN ·
3D · Brain
1 Introduction
Alzheimer’s disease (AD) is the main cause of dementia in the elderly. It is symp-
tomatically characterized by loss of memory and other intellectual abilities to
? Data used in preparation of this article were obtained from the Alzheimer’s Disease
Neuroimaging Initiative (ADNI) database (adni.loni.usc.edu). As such, the inves-
tigators within the ADNI contributed to the design and implementation of ADNI
and/or provided data but did not participate in analysis or writing of this report.
A complete listing of ADNI investigators can be found at: http://adni.loni.usc.edu/
wp-content/uploads/how to apply/ADNI Acknowledgement List.pdf
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such an extent that it affects daily life. Long before memory problems occur, mi-
croscopic changes related to cell death take place and slowly progress over time.
Radiologically, neurodegeneration is the hallmark of AD, starting in the tempo-
ral lobe and then spreading all over the brain. However, since all brains from
elderly people are affected by atrophy, it is a difficult task (even for experienced
radiologists) to discriminate normal age-related atrophy from AD-mediated at-
rophy.
In this context, machine learning models provide great potential to capture
even slight tissue alterations. State-of-the-art models for image classification
are convolutional neural networks (CNNs), which have recently been applied
to medical imaging data for various use cases [5], including AD detection. The
key idea behind CNNs is inspired by the mechanism of receptive fields in the
primate visual cortex: Local convolutional filters and pooling operations are
applied successively to extract regional information. In contrast to traditional
machine learning-based approaches, CNNs do not rely on hand-crafted features
but find meaningful representations of the input data during training.
Although CNNs deliver good classification results, they are difficult to visu-
alize and interpret. In medical decision making, however, it is critical to explain
the behavior of a machine learning model and let medical experts verify the di-
agnosis. A number of visualization methods have been suggested that highlight
regions in an input image with strong influence on the classification decision
[9,10,12,11]. Such heatmaps constitute the basis for understanding and inter-
preting machine learning models, optimally together with clinicians.
In this work, we compare four visualization methods (sensitivity analysis,
guided backpropagation, occlusion and brain area occlusion) on a 3D CNN,
which was trained to classify structural MRI scans of the brain into AD patients
and normal elderly controls (NCs).
2 Related Work
2.1 Alzheimer Classification
A number of machine learning models have been applied to Alzheimer detection.
Some use traditional approaches with hand-crafted features, while most recent
papers employ deep convolutional networks. For an overview, we refer the reader
to Table 1 in Khvostikov et al. [3]. We identified three studies that use a model
and training procedure similar to ours (i.e. 3D CNN, full-brain structural MRI
scans, AD/NC classification) [8,2,4]: In contrast to our study, Payan et al. [8]
and Hosseini-Asl et al. [2] pretrain their convolutional layers with an unsuper-
vised autoencoder. Korolev et al. [4] train from scratch, but use more complex
networks. The CNN architecture in our study is partly inspired by a model in
Khvostikov et al. [3], even though they only train on images of the hippocampus.
2.2 Visualization Methods
A range of visualization methods for CNNs have recently been developed. While
some methods aim to find prototypes for classes, we only use methods that ex-
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plain the CNN decision for a specific sample [9,10,12] (see methodological details
below). We found two studies that apply visualization methods to AD classifica-
tion in a similar way as we do: Korolev et al. [4] employ the occlusion method on
a deep CNN. While they show similar results like ours (focus on hippocampus
and ventricles), they do not compare different visualization methods or analyze
the relevance distribution in detail. Yang et al. [11] use a segmentation-based
occlusion (similar to our brain area occlusion), but reach inconclusive results. To
the best of our knowledge, this is the first study that comprehensively compares
different visualization methods on CNNs for AD detection.
3 Methods
3.1 Data
Data used in the preparation of this article were obtained from the Alzheimer’s
Disease Neuroimaging Initiative (ADNI) database (adni.loni.usc.edu). The ADNI
was launched in 2003 as a public-private partnership, led by Principal Investiga-
tor Michael W. Weiner, MD. The primary goal of ADNI has been to test whether
serial magnetic resonance imaging (MRI), positron emission tomography (PET),
other biological markers, and clinical and neuropsychological assessment can be
combined to measure the progression of mild cognitive impairment (MCI) and
early Alzheimer’s disease (AD).
For this study we used structural MRI data of patients with Alzheimer’s
disease (AD) and normal controls (NC) from phase 1 of ADNI who were included
in the ”MRI collection - Standardized 1.5T List - Annual 2 year”. For each
subject, this data collection offers structural MRI scans of the full brain for up
to three time points (screening, 12 and 24 months; sometimes multiple scans
per visit). We excluded scans with mild cognitive disorder (MCI) and two scans
for which our preprocessing pipeline failed. In total, our dataset comprises 969
individual scans (475 AD, 494 NC) from 344 subjects (193 AD, 151 NC).
All scans were acquired with 1.5 Tesla scanners at various sites and had
undergone gradient non-linearity, intensity inhomogeneity and phantom-based
distortion correction. We downloaded T1-weighted MPRAGE scans and non-
linearly registered all images to a 1 mm isotropic ICBM template using ANTs
(http://stnava.github.io/ANTs/), resulting in volumes of 193× 229× 193.
For training, we split this dataset using 5-fold cross validation. The split is
performed on the level of patients to prevent the network from seeing images of
the same patient during training and testing. For the visualization methods, we
used a fixed split with 30 AD and 30 NC patients in the test set.
3.2 Model
Our model consists of four convolutional layers (with filter size 3 × 3 × 3 and
8/16/32/64 feature maps) and two fully-connected layers (128/64 neurons; this
architecture is inspired by a model in Khvostikov et al. [3]). We apply batch
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normalization and pooling after each convolution and dropout of 0.8 before the
first fully-connected layer. The network has two output neurons with softmax
activation. We train with cross-entropy loss and the Adam optimizer (learning
rate 0.0001, batch size 5) for 20 epochs. Before feeding the brain scans to the
network, we remove the skull and normalize each voxel to have mean 0 and
standard deviation 1 across the training set.
3.3 Visualization Methods
In this section, we briefly review the four visualization methods we used in this
study (see also the review by Montavon et al. [6]). All of these methods produce
a heatmap over the input image, which indicates the relevance of image pixels for
the classification decision. PyTorch implementations of all visualization methods
will be made available at http://github.com/jrieke/cnn-interpretability.
Sensitivity Analysis (Backpropagation) [9] The gradient of the network’s
output probability w.r.t. the input image is calculated. For a given image pixel,
this gradient describes how much the output probability changes when the pixel
value changes. In neural networks, the gradient can be easily computed via the
backpropagation algorithm, which is used for training. As relevance score, we
take the absolute value of the gradient.
Guided Backpropagation [10] This method is a modified version of sen-
sitivity analysis, in which the negative gradients are set to 0 at ReLU layers
during the backward pass. This is equivalent to a combination of Backpropaga-
tion and Deconvolution and leads to more focused heatmaps. As above, we take
the absolute value of the gradient as the relevance score.
Occlusion [12] A part of the image is occluded with a black or gray patch
and the network output is recalculated. If the probability for the target class
decreases compared to the original image, this image region is considered to be
relevant. To get a relevance heatmap, we slide the patch across the image and
plot the difference between unoccluded and occluded probability (for AD or NC).
We use a patch of size 40× 40× 40 with value 0.
Brain Area Occlusion This method is a modification of occlusion, in which we
occlude an entire brain area based on the Automated Anatomical Labeling atlas
(AAL, http://www.gin.cnrs.fr/en/tools/aal-aal2/). This method was inspired by
a segmentation-based visualization in Yang et al. [11].As for occlusion, we report
the difference between unoccluded and occluded probability (for AD or NC).
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Fig. 1. Relevance heatmaps for all visualization methods, averaged over AD (top) and
NC (bottom) samples in the test set. Red indicates relevance, i.e. a red area was
important for the network’s classification decision. Numbers indicate slice positions
(out of 229 coronal slices).
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4 Results
4.1 Classification
Using 5-fold cross-validation, our network achieves a classification accuracy of
0.77 ± 0.06 and ROC AUC of 0.78 ± 0.04 (both mean ± standard deviation).
This is comparable to recent studies for other convolutional networks [8,2,4].
For example, Korolev et al. [4], who use a similar model and training procedure,
achieve a similar accuracy of 0.79± 0.08, but with a better ROC AUC of 0.88±
0.08. Please note that our focus was on the different visualization methods and
not on optimizing the network.
4.2 Relevant brain areas
Fig. 1 shows relevance heatmaps for all visualizations methods, averaged over
AD and NC samples in the test set. Since there is no ground truth available
for such heatmaps, we validate our results by focusing on specific brain areas
that were associated with AD in the medical literature. We identified the most
relevant brain areas for each visualization method by summing the relevance in
each area (according to the AAL atlas). Table 1 lists the four most relevant brain
areas for each method, again averaged over AD and NC samples.
For both AD and NC patients, we can see that the main focus of the network
is on the temporal lobe, especially its medial part. This brain area, containing
the hippocampus and other structures associated with memory, has been em-
pirically linked to AD [1]. The hippocampus itself is usually one of the earliest
areas affected by AD [7]. In our experiments, we observe some relevance on the
hippocampus, but usually the whole area around it is crucial for the network’s
decision. This may be explained by the fact that our samples contain only ad-
vanced forms of the disease.
Table 1. Most relevant brain areas per visualization method, averaged over AD (top)
and NC (bottom) samples in the test set. Values in brackets give fraction of summed
relevance in this brain area, divided by the summed relevance in the whole brain.
Sensitivity Analysis
(Backpropagation)
Guided
Backpropagation
Occlusion
Brain Area
Occlusion
AD
TemporalMid (6.1 %)
TemporalInf (5.9 %)
Fusiform (4.6 %)
CerebelumCrus1 (3.8 %)
TemporalMid (7.0 %)
TemporalInf (5.7 %)
FrontalMid (4.2 %)
Fusiform (3.9 %)
TemporalMid (12.1 %)
TemporalInf (9.2 %)
Fusiform (6.2 %)
ParaHippocampal (5.4 %)
TemporalMid (29.7 %)
TemporalInf (14.8 %)
TemporalSup (4.4 %)
Hippocampus (4.1 %)
NC
TemporalMid (6.1 %)
TemporalInf (5.8 %)
Fusiform (4.5 %)
CerebelumCrus1 (3.8 %)
CerebelumCrus1 (4.6 %)
TemporalMid (4.5 %)
TemporalInf (4.5 %)
FrontalMid (4.1 %)
TemporalMid (6.2 %)
TemporalSup (4.9 %)
CerebelumCrus1 (4.9 %)
Insula (4.7 %)
TemporalMid (20.4 %)
TemporalInf (12.8 %)
Fusiform (7.2 %)
TemporalSup (6.2 %)
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In addition to temporal regions, we observe some relevance attributed to
other areas across the brain (especially in the gradient-based visualization meth-
ods). We find that the distribution of relevance varies between patients: Some
brains have strong relevance in the temporal lobe, while in others, the cortex
plays a crucial role.
Lastly, we note that the heatmaps for AD and NC samples are quite similar.
This makes sense, given that the network should focus on the same regions to
detect presence or absence of the disease. Some differences between AD and
NC can be found for the occlusion method. We speculate that this might be an
artifact of our specific setting (the network might confuse the occlusion patch
with brain atrophy, increasing the probability for AD in some brain areas).
4.3 Differences between visualization methods
Although all visualization methods focus on similar brain areas, we can spot
some differences: Occlusion and brain area occlusion are more focused on specific
regions, while relevance in the gradient-based methods seems more distributed.
Obviously, the occlusion-based approaches cannot deal with large areas of dis-
tributed relevance (e.g. in the cortex), because these areas will never be cov-
ered up completely by the occlusion patch. Therefore, we recommend to apply
gradient-based instead of occlusion-based visualization methods for use cases
where the relevance is presumably distributed across the input image. Moreover,
we find that brain area occlusion is indeed a very natural approach for our con-
text, but it suffers from the fact that only one brain region is covered up at a
time. In our case, this leads to very high relevance for the temporal lobe, but
hardly any relevance for other brain structures.
To compare the visualization methods quantitatively, we computed Euclidean
distances between all average heatmaps (
√∑
i (Ai −Bi)2, where A and B are
the average heatmaps of two distinct methods and i is the voxel location). The
distances are shown in Table 2. In accordance with the visual impression, we
find that the gradient-based methods are relatively similar to each other (i.e.
low Euclidean distance). The only method that deviates strongly from all other
Table 2. Euclidean distance between relevance heatmaps (averaged over all AD / NC
samples in the test set) in 10−4.
Sensitivity Analysis
(Backpropagation)
Guided
Backpropagation
Occlusion
Brain Area
Occlusion
Sensitivity Analysis
(Backpropagation)
0.00 / 0.00 4.09 / 4.36 5.15 / 4.09 11.48 / 9.04
Guided
Backpropagation
4.09 / 4.36 0.00 / 0.00 6.47 / 5.83 11.36 / 9.80
Occlusion 5.15 / 4.09 6.47 / 5.83 0.00 / 0.00 11.16 / 9.66
Brain Area
Occlusion
11.48 / 9.04 11.36 / 9.80 11.16 / 9.66 0.00 / 0.00
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methods is brain area occlusion, which (as stated above) only attributes relevance
to a few image regions.
5 Conclusion
In this study, we trained a 3D CNN for Alzheimer classification and applied
various visualization methods. We show that our CNN indeed focuses on brain
regions associated with AD, in particular the medial temporal lobe. This is
consistent across all four visualization methods. Interestingly, the distribution of
relevance varies between patients, with some having a stronger focus on the tem-
poral lobe, whereas for others more cortical areas were involved. We hope that
explaining classifier decisions in this way can pave the way for machine learning
models in critical areas like medicine and will increase trust in computer-based
decision support systems. Our results also show that the visualization methods
differ in their explanations. Therefore, we strongly recommend to compare avail-
able visualization methods for a specific application area and not “blindly” trust
the results of one method.
For future research, we identified three main areas: First, other visualization
methods [6] could be implemented and compared to our results. Second, future
studies might apply our workflow to preconditions of Alzheimer’s disease, i.e.
mild cognitive impairment, and measures of clinical disability. Third, it would
be interesting to produce some form of ground truth for the relevance heatmaps,
e.g. by implementing simulation models that control for the level of separability
or location of differences.
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